Literature DB >> 30694167

How Can Radiomics Be Consistently Applied across Imagers and Institutions?

Peter Steiger1, Rohit Sood1.   

Abstract

Mesh：

Year:  2019        PMID： 30694167     DOI： 10.1148/radiol.2019190051

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  5 in total

1.  MRI-based random survival Forest model improves prediction of progression-free survival to induction chemotherapy plus concurrent Chemoradiotherapy in Locoregionally Advanced nasopharyngeal carcinoma.

Authors:  Wei Pei; Chen Wang; Hai Liao; Xiaobo Chen; Yunyun Wei; Xia Huang; Xueli Liang; Huayan Bao; Danke Su; Guanqiao Jin
Journal:  BMC Cancer       Date:  2022-07-06       Impact factor: 4.638

2.  Predicting Progression-Free Survival Using MRI-Based Radiomics for Patients With Nonmetastatic Nasopharyngeal Carcinoma.

Authors:  Hesong Shen; Yu Wang; Daihong Liu; Rongfei Lv; Yuanying Huang; Chao Peng; Shixi Jiang; Ying Wang; Yongpeng He; Xiaosong Lan; Hong Huang; Jianqing Sun; Jiuquan Zhang
Journal:  Front Oncol       Date:  2020-05-12       Impact factor: 6.244

3.  Machine Learning Radiomics Model for Early Identification of Small-Cell Lung Cancer on Computed Tomography Scans.

Authors:  Rajesh P Shah; Heather M Selby; Pritam Mukherjee; Shefali Verma; Peiyi Xie; Qinmei Xu; Millie Das; Sachin Malik; Olivier Gevaert; Sandy Napel
Journal:  JCO Clin Cancer Inform       Date:  2021-06

4.  Tumor grading of soft tissue sarcomas using MRI-based radiomics.

Authors:  Jan C Peeken; Matthew B Spraker; Carolin Knebel; Hendrik Dapper; Daniela Pfeiffer; Michal Devecka; Ahmed Thamer; Mohamed A Shouman; Armin Ott; Rüdiger von Eisenhart-Rothe; Fridtjof Nüsslin; Nina A Mayr; Matthew J Nyflot; Stephanie E Combs
Journal:  EBioMedicine       Date:  2019-09-12       Impact factor: 8.143

5.  A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients.

Authors:  Jan C Peeken; Mohamed A Shouman; Markus Kroenke; Isabel Rauscher; Tobias Maurer; Jürgen E Gschwend; Matthias Eiber; Stephanie E Combs
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-05-28       Impact factor: 9.236
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.